Biotech / MedTech
Temasek’s ClavystBio backs UK biotech Cirrus Therapeutics’s $11M funding
Cirrus Therapeutics, an United Kingdom-based ocular immunology-focused biotech, announced Wednesday the close of an $11 million seed financing to advance its pipeline of gene and cell therapies aimed at improving quality of life and extending the ocular healthspan of patients with chronic blinding diseases.
Singapore-based biotechnology company Terra Oleo raises $3.1M funding
Terra Oleo, a Singapore-based biotechnology company, announced Thursday its emergence from stealth with $3.1 million in funding from a group of investors, and support from Breakthrough Energy’s prestigious Fellows Program.
Singapore’s Greenitio raises $1.5M in Seed round led by SGInnovate
Greenitio, a Singapore-based startup developing functional biopolymers for cosmetics and specialty chemical applications, has raised $1.5 million in Seed funding to accelerate its path to commercial readiness.
Betagro Ventures partners with allies to back BiomEdit’s poultry bacteria product in $18.4M Series B round
Betagro Public Company (BTG), an integrated food company in Thailand, through its venture arm, Betagro Ventures, has partnered with global allies to fund BiomEdit, a U.S.-based animal health biotechnology company, in its $18.4 million Series B round.
Report: investors favor APAC markets as Biotech destinations amid US-China tensions
Markets in Asia Pacific (APAC) are rapidly gaining ground as credible innovation hubs amid the reshaping of global biotech strategies, driven by geopolitical tensions and significant US research funding cuts, a new report revealed on Thursday.
Temasek’s ClavystBio, Lightstone Ventures back Allay Therapeutics’ $57.5M Series D financing
Allay Therapeutics, a clinical-stage biotechnology company, announced last Thursday the completion of a $57.5 million Series D financing round with leading global investors.
Hong Kong’s PHASE Scientific raises $34M Series A round to advance urine-based diagnostic technology for early disease detection
PHASE Scientific International Limited, a Hong Kong-based biotechnology company, announced Tuesday the successful completion of a $34 million Series A funding round.
Unlocking Southeast Asia’s multi-billion dollar biotech potential With AI
With partnerships across both government and private sectors, Southeast Asia can create an ecosystem that supports sustainable, long-term growth in AI-powered healthcare, enabling breakthroughs that improve patient outcomes and save lives.
Malaysia, Japan seal $310M in green bioeconomy
Malaysia and Japan have marked a new milestone in green bioeconomy cooperation with the signing of three strategic agreements worth MYR 1.34 billion ($310 million) at Expo 2025 Osaka.
Thailand’s MUU secures strategic investment from A2D Ventures, Leave a Nest Japan and a Japanese food conglomerate
MUU, Thailand’s first animal-free dairy biotech startup, has secured strategic investment from A2D Ventures, Leave a Nest Japan, and another leading Japanese food conglomerate.
